[1]
Biagtan M, Viswanathan R, Bush RK. Immunotherapy for house dust mite sensitivity: where are the knowledge gaps? Current allergy and asthma reports. 2014 Dec:14(12):482. doi: 10.1007/s11882-014-0482-0. Epub
[PubMed PMID: 25354663]
[2]
Yang L, Zhu R. Immunotherapy of house dust mite allergy. Human vaccines & immunotherapeutics. 2017 Oct 3:13(10):2390-2396. doi: 10.1080/21645515.2017.1364823. Epub
[PubMed PMID: 28853977]
[3]
Banerjee S, Resch Y, Chen KW, Swoboda I, Focke-Tejkl M, Blatt K, Novak N, Wickman M, van Hage M, Ferrara R, Mari A, Purohit A, Pauli G, Sibanda EN, Ndlovu P, Thomas WR, Krzyzanek V, Tacke S, Malkus U, Valent P, Valenta R, Vrtala S. Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis. The Journal of investigative dermatology. 2015 Jan:135(1):102-109. doi: 10.1038/jid.2014.271. Epub 2014 Aug 7
[PubMed PMID: 24999597]
[4]
Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ, Stewart GA, Taylor GW, Garrod DR, Cannell MB, Robinson C. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. The Journal of clinical investigation. 1999 Jul:104(1):123-33
[PubMed PMID: 10393706]
[5]
Blythe ME, Williams JD, Smith JM. Distribution of pyroglyphid mites in Birmingham with particular reference to Euroglyphus maynei. Clinical allergy. 1974 Mar:4(1):25-33
[PubMed PMID: 4824570]
[6]
Thomas WR, Smith WA, Hales BJ. The allergenic specificities of the house dust mite. Chang Gung medical journal. 2004 Aug:27(8):563-9
[PubMed PMID: 15553602]
[7]
Bousquet J, Dahl R, Khaltaev N. Global Alliance against Chronic Respiratory Diseases. The European respiratory journal. 2007 Feb:29(2):233-9
[PubMed PMID: 17264322]
[8]
Weghofer M, Grote M, Resch Y, Casset A, Kneidinger M, Kopec J, Thomas WR, Fernández-Caldas E, Kabesch M, Ferrara R, Mari A, Purohit A, Pauli G, Horak F, Keller W, Valent P, Valenta R, Vrtala S. Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. Journal of immunology (Baltimore, Md. : 1950). 2013 Apr 1:190(7):3059-67. doi: 10.4049/jimmunol.1202288. Epub 2013 Mar 4
[PubMed PMID: 23460742]
[9]
Sears MR,Herbison GP,Holdaway MD,Hewitt CJ,Flannery EM,Silva PA, The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 1989 Jul;
[PubMed PMID: 2758355]
[10]
King C, Brennan S, Thompson PJ, Stewart GA. Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. Journal of immunology (Baltimore, Md. : 1950). 1998 Oct 1:161(7):3645-51
[PubMed PMID: 9759888]
[11]
International Workshop Report. Dust mite allergens and asthma: a worldwide problem. International Workshop report. Bulletin of the World Health Organization. 1988:66(6):769-80
[PubMed PMID: 3069235]
[12]
Chapman MD, Wünschmann S, Pomés A. Proteases as Th2 adjuvants. Current allergy and asthma reports. 2007 Sep:7(5):363-7
[PubMed PMID: 17697645]
[13]
Kalsheker NA, Deam S, Chambers L, Sreedharan S, Brocklehurst K, Lomas DA. The house dust mite allergen Der p1 catalytically inactivates alpha 1-antitrypsin by specific reactive centre loop cleavage: a mechanism that promotes airway inflammation and asthma. Biochemical and biophysical research communications. 1996 Apr 5:221(1):59-61
[PubMed PMID: 8660343]
[14]
. Dust mite allergens and asthma--a worldwide problem. The Journal of allergy and clinical immunology. 1989 Feb:83(2 Pt 1):416-27
[PubMed PMID: 2645343]
[15]
Custovic A, Taggart SC, Francis HC, Chapman MD, Woodcock A. Exposure to house dust mite allergens and the clinical activity of asthma. The Journal of allergy and clinical immunology. 1996 Jul:98(1):64-72
[PubMed PMID: 8765819]
[16]
Custovic A, Chapman M. Risk levels for mite allergens. Are they meaningful? Allergy. 1998:53(48 Suppl):71-6
[PubMed PMID: 10096813]
[17]
Jang YH, Choi JK, Jin M, Choi YA, Ryoo ZY, Lee HS, Park PH, Kim SU, Kwon TK, Jang MH, Im SH, Moon SY, Lee WJ, Lee SJ, Kim DW, Kim SH. House Dust Mite Increases pro-Th2 Cytokines IL-25 and IL-33 via the Activation of TLR1/6 Signaling. The Journal of investigative dermatology. 2017 Nov:137(11):2354-2361. doi: 10.1016/j.jid.2017.03.042. Epub 2017 Jul 4
[PubMed PMID: 28684329]
[18]
Turjanmaa K, Darsow U, Niggemann B, Rancé F, Vanto T, Werfel T. EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy. 2006 Dec:61(12):1377-84
[PubMed PMID: 17073865]
[19]
Sturm GJ, Kranzelbinder B, Sturm EM, Heinemann A, Groselj-Strele A, Aberer W. The basophil activation test in the diagnosis of allergy: technical issues and critical factors. Allergy. 2009 Sep:64(9):1319-26. doi: 10.1111/j.1398-9995.2009.02004.x. Epub 2009 Feb 20
[PubMed PMID: 19243362]
[20]
Gosepath J, Amedee RG, Mann WJ. Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis. The Laryngoscope. 2005 Mar:115(3):512-6
[PubMed PMID: 15744168]
[21]
Li L, Qian J, Zhou Y, Cui Y. Domestic mite-induced allergy: Causes, diagnosis, and future prospects. International journal of immunopathology and pharmacology. 2018 Jan-Dec:32():2058738418804095. doi: 10.1177/2058738418804095. Epub
[PubMed PMID: 30350752]
Level 2 (mid-level) evidence
[22]
Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. International archives of allergy and immunology. 2002 Apr:127(4):259-68
[PubMed PMID: 12021544]
[23]
Jaén A, Sunyer J, Basagaña X, Chinn S, Zock JP, Antó JM, Burney P, European Community Respiratory Health Survey. Specific sensitization to common allergens and pulmonary function in the European Community Respiratory Health Survey. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2002 Dec:32(12):1713-9
[PubMed PMID: 12653161]
Level 3 (low-level) evidence
[24]
Wilson JM, Platts-Mills TAE. Home Environmental Interventions for House Dust Mite. The journal of allergy and clinical immunology. In practice. 2018 Jan-Feb:6(1):1-7. doi: 10.1016/j.jaip.2017.10.003. Epub
[PubMed PMID: 29310755]
[25]
Li CL, Lin HC, Lin CY, Hsu TF. Effectiveness of Hypertonic Saline Nasal Irrigation for Alleviating Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis. Journal of clinical medicine. 2019 Jan 9:8(1):. doi: 10.3390/jcm8010064. Epub 2019 Jan 9
[PubMed PMID: 30634447]
Level 1 (high-level) evidence
[26]
Nelson HS. New forms of allergy immunotherapy for rhinitis and asthma. Allergy and asthma proceedings. 2014 Jul-Aug:35(4):271-7. doi: 10.2500/aap.2014.35.3778. Epub
[PubMed PMID: 24992546]
[27]
Eifan AO, Akkoc T, Yildiz A, Keles S, Ozdemir C, Bahceciler NN, Barlan IB. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2010 Jun:40(6):922-32. doi: 10.1111/j.1365-2222.2009.03448.x. Epub 2010 Jan 20
[PubMed PMID: 20100188]
Level 1 (high-level) evidence
[28]
Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy. 2012 Mar:67(3):302-11. doi: 10.1111/j.1398-9995.2011.02761.x. Epub 2011 Dec 12
[PubMed PMID: 22150126]
[29]
Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, Canonica GW, Passalacqua G. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. The Journal of allergy and clinical immunology. 2007 Jul:120(1):164-70
[PubMed PMID: 17543376]
Level 1 (high-level) evidence
[30]
Vrtala S, Huber H, Thomas WR. Recombinant house dust mite allergens. Methods (San Diego, Calif.). 2014 Mar 1:66(1):67-74. doi: 10.1016/j.ymeth.2013.07.034. Epub 2013 Jul 31
[PubMed PMID: 23911838]
[31]
Araki A, Ait Bamai Y, Ketema RM, Kishi R. [House Dust and Its Adverse Health Effects]. Nihon eiseigaku zasshi. Japanese journal of hygiene. 2018:73(2):130-137. doi: 10.1265/jjh.73.130. Epub
[PubMed PMID: 29848863]
[32]
Settipane RA, Kaliner MA. Chapter 14: Nonallergic rhinitis. American journal of rhinology & allergy. 2013 May-Jun:27 Suppl 1():S48-51. doi: 10.2500/ajra.2013.27.3927. Epub
[PubMed PMID: 23711042]
[33]
Huang FL, Liao EC, Yu SJ. House dust mite allergy: Its innate immune response and immunotherapy. Immunobiology. 2018 Mar:223(3):300-302. doi: 10.1016/j.imbio.2017.10.035. Epub 2017 Oct 16
[PubMed PMID: 29079219]
[34]
Kim J, Lee S, Woo SY, Han Y, Lee JH, Lee IY, Lim IS, Choi ES, Choi BW, Cheong HK, Lee SI, Ahn K. The indoor level of house dust mite allergen is associated with severity of atopic dermatitis in children. Journal of Korean medical science. 2013 Jan:28(1):74-9. doi: 10.3346/jkms.2013.28.1.74. Epub 2013 Jan 8
[PubMed PMID: 23341715]
[35]
Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet (London, England). 2011 Dec 17:378(9809):2112-22. doi: 10.1016/S0140-6736(11)60130-X. Epub 2011 Jul 23
[PubMed PMID: 21783242]
[36]
Brożek JL,Bousquet J,Agache I,Agarwal A,Bachert C,Bosnic-Anticevich S,Brignardello-Petersen R,Canonica GW,Casale T,Chavannes NH,Correia de Sousa J,Cruz AA,Cuello-Garcia CA,Demoly P,Dykewicz M,Etxeandia-Ikobaltzeta I,Florez ID,Fokkens W,Fonseca J,Hellings PW,Klimek L,Kowalski S,Kuna P,Laisaar KT,Larenas-Linnemann DE,Lødrup Carlsen KC,Manning PJ,Meltzer E,Mullol J,Muraro A,O'Hehir R,Ohta K,Panzner P,Papadopoulos N,Park HS,Passalacqua G,Pawankar R,Price D,Riva JJ,Roldán Y,Ryan D,Sadeghirad B,Samolinski B,Schmid-Grendelmeier P,Sheikh A,Togias A,Valero A,Valiulis A,Valovirta E,Ventresca M,Wallace D,Waserman S,Wickman M,Wiercioch W,Yepes-Nuñez JJ,Zhang L,Zhang Y,Zidarn M,Zuberbier T,Schünemann HJ, Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. The Journal of allergy and clinical immunology. 2017 Oct;
[PubMed PMID: 28602936]